Breathlessness and opioid prescribing in COPD in general practice: a cross-sectional, observational study

Chronic breathlessness is a disabling syndrome, prevalent in people with advanced chronic obstructive pulmonary disease (COPD). Regular, low-dose, oral sustained-release morphine is approved in Australia to reduce symptomatic chronic breathlessness. We aimed to determine the current prescribing patt...

Descripción completa

Detalles Bibliográficos
Autores principales: Currow, David C., Johnson, Miriam J., Pollack, Allan, Ferreira, Diana H., Kochovska, Slavica, Ekström, Magnus, Harrison, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402382/
https://www.ncbi.nlm.nih.gov/pubmed/32775398
http://dx.doi.org/10.1183/23120541.00299-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402382/
https://www.ncbi.nlm.nih.gov/pubmed/32775398
http://dx.doi.org/10.1183/23120541.00299-2019

Ejemplares similares